Differential capability for phagocytosis of apoptotic and necrotic leukemia cells by human peripheral blood dendritic cell subsets

Journal of Leukocyte Biology

Volumn 77, Issue 5, 2005, Pages 689-698

  Dalgaard, Jakob ^a   Beckstrøm, Karen J ^a   Jahnsen, Frode L ^a   Brinchmann, Jan E ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

CD11c+; CD36; MoDC; PDC; Uptake

Indexed keywords

BETA5 INTEGRIN; CD36 ANTIGEN; CD83 ANTIGEN; GLYCOPROTEIN P 15095; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; INTERLEUKIN 4; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL MATURATION; CELL SUBPOPULATION; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOTHERAPY; INCUBATION TIME; LEUKEMIA CELL; PERIPHERAL CIRCULATION; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIGENS, CD11C; APOPTOSIS; CELL DIFFERENTIATION; CULTURE MEDIA, SERUM-FREE; DENDRITIC CELLS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTEGRIN BETA CHAINS; INTERLEUKIN-4; K562 CELLS; LEUKEMIA, ERYTHROBLASTIC, ACUTE; MONOCYTES; NECROSIS; PHAGOCYTOSIS; PLASMA CELLS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 18244363341     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1204711     Document Type: Article

References (51)

1. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y. J., Pulendran, B., Palucka, K. (2000) Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767-811.
2. O'Neill, D. W., Adams, S., Bhardwaj, N. (2004) Manipulating dendritic cell biology for the active immunotherapy of cancer. Blood 104, 2235-2246.
3. Watts, C. (1997) Capture and processing of exogenous antigens for presentation on MHC molecules. Annu. Rev. Immunol. 15, 821-850.
4. Ackerman, A. L., Cresswell, P. (2004) Cellular mechanisms governing cross-presentation of exogenous antigens. Nat. Immunol. 5, 678-684.
5. Schnurr, M., Scholz, C., Rothenfusser, S., Galambos, P., Dauer, M., Robe, J., Endres, S., Eigler, A. (2002) Apoptotic pancreatic tumor cells are superior to cell lysates in promoting cross-priming of cytotoxic T cells and activate NK and γδ T cells. Cancer Res. 62, 2347-2352.
6. Gronard, G., Rissoan, M. C., Filgueira, L., Durand, I., Banchereau, J., Liu, Y. J. (1997) The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J. Exp. Med. 185, 1101-1111.
7. O'Doherty, U., Peng, M., Gezelter, S., Swiggard, W. J., Betjes, M., Bhardwaj, N., Steinman, R. M. (1994) Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology 82, 487-493.
8. Olweus, J., BitMansour, A., Warnke, R., Thompson, P. A., Carballido, J., Picker, L. J., Lund-Johansen, F. (1997) Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin. Proc. Natl. Acad. Sci. USA 94, 12551-12556.
9. MacDonald, K. P., Munster, D. J., Clark, G. J., Dzionek, A., Schmitz, J., Hart, D. N. (2002) Characterization of human blood dendritic cell subsets. Blood 100, 4512-4520.
10. Dzionek, A., Fuchs, A., Schmidt, P., Crenter, S., Zysk, M., Miltenyi, S., Buck, D. W., Schmitz, J. (2000) BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J. Immunol. 165, 6037-6046.
11. Wang, Y. H., Liu, Y. J. (2004) Mysterious origin of plasmacytoid dendritic cell precursors. Immunity 21, 1-2.
12. Sallusto, F., Lanzavecchia, A. (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. Exp. Med. 179, 1109-1118.
13. Albert, M. L., Pearce, S. F., Francisco, L. M., Sauter, B., Roy, P., Silverstein, R. L., Bhardwaj, N. (1998) Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J. Exp. Med. 188, 1359-1368.
14. Sauter, B., Albert, M. L., Francisco, L., Larsson, M., Somersan, S., Bhardwaj, N. (2000) Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 191, 423-434.
15. Scandella, E., Men, Y., Gillessen, S., Forster, R., Groettrup, M. (2002) Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood 100, 1354-1361.
16. Jefford, M., Schnurr, M., Toy, T., Masterman, K. A., Shin, A., Beecroft, T., Tai, T. Y., Shortman, K., Shackleton, M., Davis, I. D., Parente, P., Luft, T., Chen, W., Cebon, J., Maraskovsky, E. (2003) Functional comparison of DCs generated in vivo with Flt3 ligand or in vitro from blood monocytes: differential regulation of function by specific classes of physiologic stimuli. Blood 102, 1753-1763.
17. Geissmann, F., Prost, C., Mounet, J. P., Dy, M., Brousse, N., Hermine, O. (1998) Transforming growth factor β1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J. Exp. Med. 187, 961-966.
18. Ito, T., Inaba, M., Inaba, K., Toki, J., Sogo, S., Iguchi, T., Adachi, Y., Yamaguchi, K., Amakawa, R., Valladeau, J., Saeland, S., Fukuhara, S., Ikehara, S. (1999) A CD1a+/CD11e+ subset of human blood dendritic cells is a direct precursor of Langerhans cells. J. Immunol. 163, 1409-1419.
19. Zuniga, E. I., McGavern, D. B., Pruneda-Paz, J. L., Teng, C., Oldstone, M. B. (2004) Bone marrow plasmacytoid dendritic cells can differentiate into myeloid dendritic cells upon virus infection. Nat. Immunol. 5, 1227-1234.
20. de la Rosa, G., Longo, N., Rodriguez-Fernandez, J. L., Puig-Kroger, A., Pineda, A., Corbi, A. L., Sanchez-Mateos, P. (2003) Migration of human blood dendritic cells across endothelial cell monolayers: adhesion molecules and chemokines involved in subset-specific transmigration. J. Leukoc. Biol. 73, 639-649.
21. Jarrossay, D., Napolitani, G., Colonna, M., Sallusto, F., Lanzavecchia, A. (2001) Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur. J. Immunol. 31, 3388-3393.
22. Osugi, Y., Vuckovic, S., Hart, D. N. (2002) Myeloid blood CD11c(+) dendritic cells and monocyte-derived dendritic cells differ in their ability to stimulate T lymphocytes. Blood 100, 2858-2866.
23. Robinson, S. P., Patterson, S., English, N., Davies, D., Knight, S. C., Reid, C. D. (1999) Human peripheral blood contains two distinct lineages of dendritic cells. Eur. J. Immunol. 29, 2769-2778.
24. Stent, G., Reece, J. C., Baylis, D. C., Ivinson, K., Paukovics, G., Thomson, M., Cameron, P. U. (2002) Heterogeneity of freshly isolated human tonsil dendritic cells demonstrated by intracellular markers, phagocytosis, and membrane dye transfer. Cytometry 48, 167-176.
25. Dalgaard, J., Beckstroem, K. J., Brinchmann, J. E. (2003) Uptake of apoptotic K562 leukaemia cells by immature dendritic cells is greatly facilitated by serum. Scand. J. Immunol. 58, 541-549.
26. Lyons, A. B. (2000) Analyzing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J. Immunol. Methods 243, 147-154.
27. Binder, R. J., Han, D. K., Srivastava, P. K. (2000) CD91: a receptor for heat shock protein gp96. Nat. Immunol. 1, 151-155.
28. Grassi, F., Dezutter-Dambuyant, C., McIlroy, D., Jacquet, C., Yoneda, K., Imamura, S., Boumsell, L., Schmitt, D., Autran, B., Debre, P., Hosmalin, A. (1998) Monocyte-derived dendritic cells have a phenotype comparable to that of dermal dendritic cells and display ultrastructural granules distinct from Birbeck granules. J. Leukoc. Biol. 64, 484-493.
29. Caux, C., Vanbervliet, B., Massacrier, C., Dezutter-Dambuyant, C., Saint-Vis, B., Jacquet, C., Yoneda, K., Imamura, S., Schmitt, D., Banchereau, J. (1996) CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF α. J. Exp. Med. 184, 695-706.
30. Callahan, M. K., Halleck, M. S., Krahling, S., Henderson, A. J., Williamson, P., Schlegel, R. A. (2003) Phosphatidylserine expression and phagocytosis of apoptotic thymocytes during differentiation of monocytic cells. J. Leukoc. Biol. 74, 846-856.
31. Fonteneau, J. F., Cilliet, M., Larsson, M., Dasilva, I., Munz, C., Liu, Y. J., Bhardwaj, N. (2003) Activation of influenza virus-specific CD4+ and CD8+ T cells: a new role for plasmacytoid dendritic cells in adaptive immunity. Blood 101, 3520-3526.
32. Kohrgruber, N., Halanek, N., Croger, M., Winter, D., Rappersberger, K., Schmitt-Egenolf, M., Stingl, C., Maurer, D. (1999) Survival, maturation, and function of CD11c- and CD11c+ peripheral blood dendritic cells are differentially regulated by cytokines. J. Immunol. 163, 3250-3259.
33. de Heer, H. J., Hammad, H., Soullie, T., Hijdra, D., Vos, N., Willart, M. A., Hoogsteden, H. C., Lambrecht, B. N. (2004) Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J. Exp. Med. 200, 89-98.
34. Huang, F. P., Platt, N., Wykes, M., Major, J. R., Powell, T. J., Jenkins, C. D., MacPherson, G. G. (2000) A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J. Exp. Med. 191, 435-444.
35. Morelli, A. E., Larregina, A. T., Shufesky, W. J., Zahorchak, A. F., Logar, A. J., Papworth, G. D., Wang, Z., Watkins, S. C., Falo Jr., L. D., Thomson, A. W. (2003) Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production. Blood 101, 611-620.
36. Lauber, K., Blumenthal, S. G., Waibel, M., Wesselborg, S. (2004) Clearance of apoptotic cells: getting rid of the corpses. Mol. Cell 14, 277-287.
37. Ogden, C. A., deCathelineau, A., Hoffmann, P. R., Bratton, D., Ghebrehiwet, B., Fadok, V. A., Henson, P. M. (2001) C1q and mannose-binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J. Exp. Med. 194, 781-795.
38. Vandivier, R. W., Ogden, C. A., Fadok, V. A., Hoffmann, P. R., Brown, K. K., Botto, M., Walport, M. J., Fisher, J. H., Henson, P. M., Greene, K. E. (2002) Role of surfactant proteins A, D and C1q in the clearance of apoptotic cells in vivo and in vitro: calreticulin and CD91 as a common collectin receptor complex. J. Immunol. 169, 3978-3986.
39. van der Flier, A., Sonnenberg, A. (2001) Function and interactions of integrins. Cell Tissue Res. 305, 285-298.
40. Fadok, V. A., Bratton, D. L., Rose, D. M., Pearson, A., Ezekewitz, R. A., Henson, P. M. (2000) A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 405, 85-90.
41. Fanger, N. A., Wardwell, K., Shen, L., Tedder, T. F., Guyre, P. M. (1996) Type I (CD64) and type II (CD32) Fc γ receptor-mediated phagocytosis by human blood dendritic cells. J. Immunol. 157, 544-548.
42. Mevorach, D., Mascarenhas, J. O., Gershov, D., Elkon, K. B. (1998) Complement-dependent clearance of apoptotic cells by human macrophages. J. Exp. Med. 188, 2313-2320.
43. McIlroy, D., Gregoire, M. (2003) Optimizing dendritic cell-based anticancer immunotherapy: maturation state does have clinical impact. Cancer Immunol. Immunother. 52, 583-591.
44. Rice, A. M., Jones, K. L., Hart, D. N. (2004) DC preparations for therapy. Cytotherapy 6, 99-104.
45. Fong, L., Hou, Y., Rivas, A., Benike, C., Yuen, A., Fisher, G. A., Davis, M. M., Engleman, E. G. (2001) Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy. Proc. Natl. Acad. Sci. USA 98, 8809-8814.
46. Hsu, F. J., Benike, C., Fagnoni, F., Liles, T. M., Czerwinski, D., Taidi, B., Engleman, E. G., Levy, R. (1996) Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat. Med. 2, 52-58.
47. Reichardt, V. L., Okada, C. Y., Liso, A., Benike, C. J., Stockerl-Goldstein, K. E., Engleman, E. G., Blume, K. G., Levy, R. (1999) Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma-a feasibility study. Blood 93, 2411-2419.
48. Timmerman, J. M., Czerwinski, D. K., Davis, T. A., Hsu, F. J., Benike, C., Hao, Z. M., Taidi, B., Rajapaksa, R., Caspar, C. B., Okada, C. Y., van Beckhoven, A., Liles, T. M., Engleman, E. G., Levy, R. (2002) Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients. Blood 99, 1517-1526.
49. Maraskovsky, E., Daro, E., Roux, E., Teepe, M., Maliszewski, C. R., Hoek, J., Caron, D., Lebsack, M. E., McKenna, H. J. (2000) In vivo generation of human dendritic cell subsets by Flt3 ligand. Blood 96, 878-884.
50. Vari, F., Hart, D. N. (2004) Loading DCs with Ag. Cytotherapy 6, 111-121.
51. Ward, S., Casey, D., Labarthe, M. C., Whelan, M., Dalgleish, A., Pandha, H., Todryk, S. (2002) Immunotherapeutic potential of whole tumor cells. Cancer Immunol. Immunother. 51, 351-357.